Indica Labs, the leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce selection of the HALO image analysis platform by the Netherlands Cancer Institute (NKI) for in situ analysis of...

Wednesday 25th October | 8:00 AM PDT | 11:00 AM EDT | 4:00 PM BST Vlado Ovtcharov, Lead Algorithm Engineer, Indica Labs, Inc Dr. Kate Lillard Tunstall, CSO, Indica Labs, Inc   If you’ve attended any digital pathology or medical...

Portland OR – September 29, 2017 – MolecularMD, a provider of molecular and tissue-based clinical trial assays and diagnostics for oncology based drug development programs, has announced a partnership agreement with Indica...

Indica Labs announced today that Douglas Bowman has been appointed Vice President, Pharma Services. Mr. Bowman will play an important role as the company develops its image analysis and biomarker assay services business to support preclinical...

Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop...

Application Scientist – West Coast Application Scientist – East Coast Company Indica Labs provides software solutions for fast, quantitative evaluation of digital pathology images using HALO, our flagship image analysis platform. ...